Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Startup Find the Job has raised ₽6.6 million in funding

10/25/24 OTCI

Element allowed entry into foreign markets through local investors

10/25/24 ELMT

Inter RAO for 9 months of 2024 increased generation by 7.4%

10/25/24 IRAO

Tambovenergosbyt reported for 9 months of 2024 by RAS

10/25/24 TASB

Inter RAO reported for 9 months of 2024 by RAS

10/25/24 IRAO

UTair reported for 9 months of 2024 by RAS

10/25/24 UTAR

Rusagro plans to finalize redomiciliation by March 2025

10/25/24 AGRO

Delimobil CEO increases stake in the company 1.5 times

10/24/24 DELI

NCSP reports for 9 months of 2024 by RAS

10/24/24 NMTP

LSR reported for 9 months of 2024 by RAS

10/24/24 LSRG